FDA Adverse Event Injury Summary report: N

CORNEAT EVERPATCH

MDR report key: 19370667 · Received May 22, 2024

Report

Report Number
3029772936-2024-00002
Event Type
Injury
Date Received
May 22, 2024
Date of Event
April 24, 2024
Report Date
November 11, 2024
Manufacturer
CORNEAT VISION, LTD.
Product Code
QWU
UDI-DI
G16010362950
PMA / PMN Number
K223074
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MD, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE EVERPATCH REMAINS IMPLANTED IN THE PATIENT AND IS NOT AVAILABLE FOR EVALUATION BY THE MANUFACTURER. THE DEVICE IDENTIFIERS WERE PROVIDED, AND THE LOT HISTORY RECORDS WERE REVIEWED. THERE WERE NO DISCREPANCIES OR UNUSUAL FINDINGS. THE ROOT CAUSE INVESTIGATION IS UNDERWAY AND THE FINDINGS WILL BE PROVIDED IN A SUPPLEMENTAL REPORT. MANUFACTURER REFERENCE #: (B)(4).

Additional Manufacturer Narrative · 0

MANUFACTURER REFERENCE#: (B)(4).

Description of Event or Problem · 0

A PATIENT UNDERWENT GLAUCOMA SURGERY ON (B)(6) 2024 WITH IMPLANTATION OF A BAERVELDT GLAUCOMA IMPLANT WHERE THE CORNEAT EVERPATCH WAS USED TO REINFORCE THE SCLERA AND AID THE PHYSICAL RECONSTRUCTION OF THE OCULAR SURFACE. DURING SURGERY, THE EVERPATCH WAS NOT VISIBLE WHICH MADE IT DIFFICULT TO PERFORM LASER LYSIS. ONE DAY POSTOPERATIVELY THE PATIENT PRESENTED WITH AN INTRAOCULAR PRESSURE (IOP) OF 50 MMHG. ON (B)(6) 2024, THE BAERVELDT DEVICE WAS EXPLANTED AND REPLACED WITH AN AHMED GLAUCOMA SHUNT. FOLLOW-UP WAS REQUESTED FROM THE SURGEON WHO REPORTS THE PATIENT MAY HAVE LOST VISION. ADDITIONAL FOLLOW-UP WILL BE REQUESTED.

Description of Event or Problem · 0

ADDITIONAL PATIENT FOLLOW-UP WAS REQUESTED FROM THE SURGEON ON AUGUST 29, 2024, SEPTEMBER 5, 2024, AND SEPTEMBER 8, 2024, WITH NO ADDITIONAL INFORMATION RECEIVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1704714 CORNEAT EVERPATCH PROSTHESIS, EYELID SPACER/GRAFT, POLYMER QWU CORNEAT VISION, LTD. 1007691 20230713 G16010362950

Patients

Seq Age Sex Outcome Treatment
1 NA Male Required Intervention BAERVELDT GLAUCOMA IMPLANT.